This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Regeneron Pharmaceuticals, Inc., Yale University, Institute for Research in Biomedicine. Active years: 2013-2025.
Company Filing History:
11 out of 1,479 
10 out of 1,365 
9 out of 76 
Years Active: 2013-2025
Title: **Anthony Rongvaux: Innovator in Genetic Engineering**
Introduction
Anthony Rongvaux, based in New Haven, Connecticut, is an accomplished inventor with a notable portfolio of 10 patents. His work primarily focuses on the realm of genetic engineering, particularly in the development of genetically modified organisms and their applications in biomedical research.
Latest Patents
Among his latest innovations are groundbreaking patents such as "Genetically Modified Non-Human Animals and Methods of Use Thereof" and "Genetically Modified Mice and Engraftment." The former patent outlines methods to create genetically modified non-human animals that express human polypeptides, allowing for new avenues in research and therapeutic applications. The latter patent describes an advanced mouse model featuring humanized genes, including a knockout of the mRAG gene and the mII2rg subunit gene. This mouse model is particularly significant as it can engraft human hematopoietic stem cells, maintaining a population of human immune cells and serving as a platform for studying human pathogen infections that are difficult to replicate in standard murine models.
Career Highlights
Anthony has contributed his expertise to esteemed institutions, including Regeneron Pharmaceuticals, Inc. and Yale University. His innovative work has significantly advanced the understanding of human diseases and potential treatments.
Collaborations
During his career, Anthony has collaborated closely with notable professionals such as Sean Stevens and Andrew J. Murphy. These partnerships have fostered a rich environment for innovation and the exchange of ideas, driving forward the field of genetic engineering.
Conclusion
Anthony Rongvaux's contributions to the field of innovative genetic engineering underscore his importance as an inventor. With his impressive portfolio of patents and collaborations with leading organizations, he continues to pave the way for advancements that may revolutionize treatment methodologies for various human diseases.